BioSpace News Archive

Business

Biohaven Pharma Reports Third Quarter 2017 Financial And Business Results

Biohaven Pharma today reported financial results for the quarter ended September 30, 2017, and provided a review of recent accomplishments and anticipated upcoming milestones.

November 14, 2017

·

12 min read

Learn “Lean Lab” Terminology With the New Lean Laboratory Glossary from METTLER TOLEDO

Lean manufacturing and management principles are finding application in R&D and quality control labs around the world as companies seek to improve overall efficiency and keep up with ever-changing markets.

November 14, 2017

·

2 min read

Alpha Genesis Expands in to European Research Market

The company has embarked on a further expansion program to more fully leverage its primate expertise, research design and integration skills to deliver first-to-market innovations with European clients.

November 14, 2017

·

1 min read

Biotech Beach

Biocom Urges Senate Committee to Improve Orphan Drug Tax Credit Provision, Eliminate Provision Taxing Stock Options

The statement can be attributed to Joe Panetta, Biocom’s president and CEO.

November 14, 2017

·

4 min read

Genetown

Sage Therapeutics Prices Public Offering of Common Stock

The offering is expected to close on or about November 17, 2017, subject to the satisfaction of customary closing conditions.

November 14, 2017

·

5 min read

Business

Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update

For the quarter ended September 30, 2017, Celsion reported a net loss of $5.7 million, or $(0.70) per share, compared to a net loss of $6.4 million, or $(3.22) per share, in the same period of 2016

November 14, 2017

·

18 min read

Business

Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results

For the three months ended September 30, 2017, Mateon reported a net loss of $3.5 million, compared to a net loss of $3.2 million for the three months ended September 30, 2016.

November 14, 2017

·

4 min read

Biotech Beach

SkylineDx’s SKY92 Gene Signature Facilitates Cost-Effective, Risk-Stratified Treatment of Multiple Myeloma

This is the first study to examine the potential health economic value of RST in MM within the EU.

November 14, 2017

·

3 min read

Deals

Monopar Therapeutics Announces Acquisition of GPX-150, a Broad Spectrum Phase II Cancer Drug Candidate, Closing on $9.7M in Financing, and Filing of Form 10 Registration Statement

Monopar Therapeutics today announced the acquisition of GPX-150 from privately held Gem Pharmaceuticals concurrent with $9.7M of new financing.

November 14, 2017

·

5 min read

MMJ PhytoTech Ltd Commits A$500,000 Cornerstone Investment in eSense-Lab Limited

MMJ will be issued 2,500,000 ordinary shares in eSense at the price of A$0.20 per share, and will receive 1 free option for every 2 shares issued at a $0.30 exercise price and expiry date of 3 years from date of issue.

November 14, 2017

·

4 min read